Flexibility Drives Progress During a Rare Disease Gene Therapy Clinical Trial
Veristat was engaged by a biotech organization focusing on gene therapies for metabolic diseases to support their clinical study for the treatment of a rare human genetic lysosomal storage disorder. Through a collaborative partnership and a flexible operating model, we addressed critical patient, lab, product manufacturing, logistics, and tracking/reporting requirements to satisfy our Sponsor’s requirements at every milestone.
Download to learn how Veristat helped a biotech company address clinical operations challenges to meet changing requirements.
downloadExplore Our Key Related Services
Please fill out this form to access your resource.